Aat Biopquest
Aat Bioquest Laboratories manufactures the aat biopquest reagents distributed by Genprice. The Aat Biopquest reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact AAT Bioquest. Other Aat products are available in stock. Specificity: Aat Category: Biopquest
APC-AAT complex antibody |
|||
10-1738 | Fitzgerald | 200 ul | EUR 651.6 |
Description: Mouse monoclonal APC-AAT complex antibody |
AAT Polyclonal Conjugated Antibody |
|||
C41927 | SAB | 100ul | EUR 476.4 |
Alpha-1-Antitrypsin (AAT) Antibody |
|||
abx010340-100ul | Abbexa | 100 ul | EUR 493.2 |
Monoclonal AAT Antibody, Clone: 2B12 |
|||
APG01392G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A Monoclonal antibody against Human AAT. The antibodies are raised in Mouse and are from clone 2B12. This antibody is applicable in WB, E |
Recombinant Aeromonas Hydrophila aat Protein |
|||
VAng-Lsx0907-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4665.6 |
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein. |
Recombinant Aeromonas Hydrophila aat Protein |
|||
VAng-Lsx0907-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3163.2 |
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein. |
Recombinant Aeromonas Hydrophila aat Protein |
|||
VAng-Lsx0907-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2151.6 |
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein. |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
R32565 | NSJ Bioreagents | 100 ug | EUR 419 |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
RQ4850 | NSJ Bioreagents | 100ul | EUR 419 |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3221-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin. |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3221-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin. |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3221SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin. |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3222-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki] |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3222-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki] |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V3222SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki] |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V8013-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: The immunohistochemical staining of AAT is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin. |
Alpha 1 Antitrypsin Antibody / AAT / SERPINA1 |
|||
V8013-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: The immunohistochemical staining of AAT is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin. |